Zha L L, Shen Z Y, Zhang P
Institute of the Integration of TCM-WM, Shanghai Medical University.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1994 Feb;14(2):74-6, 67.
38 cases of ischemic apoplexy were randomly divided into three groups. Among them 26 cases were treated with type I and type III of Buyang Huanwu Tang Granule (BYHWTG) for 10 weeks, respectively. The other 12 cases served as a control group. The results showed that clinical cure and markedly effective rate were 42.3%, the total effective rate was 88.5% in BYHWTG group. The effective rate of BYHWTG type I for the treatment of ischemic apoplexy was 100% and it was superior to type III (84.6). BYHWTG could significantly improve hemorheologic indexes in the patients of ischemic apoplexy. The activity of RBC sodium pump was markedly raised from 0.210 +/- 0.003 to 0.250 +/- 0.008 1/h (P < 0.001) in BYHWTG type I. The results of this study suggested that BYHWTG had evident efficacy in the treatment of ischemic apoplexy.
38例缺血性中风患者被随机分为三组。其中26例分别用补阳还五汤颗粒（BYHWTG）I型和III型治疗10周。另外12例作为对照组。结果显示，BYHWTG组临床治愈和显效率为42.3%，总有效率为88.5%。补阳还五汤I型治疗缺血性中风的有效率为100%，优于III型（84.6%）。补阳还五汤能显著改善缺血性中风患者的血液流变学指标。补阳还五汤I型可使红细胞钠泵活性从0.210±0.003显著提高至0.250±0.008 1/h（P<0.001）。本研究结果提示，补阳还五汤治疗缺血性中风疗效显著。
